AAAAAA

   
Results: 1-8 |
Results: 8
ADJUVANT CHEMOTHERAPY IN WOMEN WITH HIGH-RISK BREAST-CANCER - AN INTENSIVE AND SHORT TREATMENT BONADONNA MODIFIED REGIMEN
Authors: VALDIVIA S GOMEZ H KAHATT C LEON L VIGIL C SANTILLANA S CASANOVA L CARRACEDO C FLORES C VALLEJOS C
Citation: S. Valdivia et al., ADJUVANT CHEMOTHERAPY IN WOMEN WITH HIGH-RISK BREAST-CANCER - AN INTENSIVE AND SHORT TREATMENT BONADONNA MODIFIED REGIMEN, Annals of oncology, 9, 1998, pp. 36-36
VP-16 (V)-IFOSFAMIDE (I)-CISPLATIN (P) IN FIRST-LINE THERAPY FOR POOR-RISK GERM-CELL TUMORS (PR-GCT)
Authors: RODRIGUEZ PW GOMEZ H CASANOVA L VALDIVIA S SANTILLANA S CARRACEDO C VAILLEJOS C
Citation: Pw. Rodriguez et al., VP-16 (V)-IFOSFAMIDE (I)-CISPLATIN (P) IN FIRST-LINE THERAPY FOR POOR-RISK GERM-CELL TUMORS (PR-GCT), Annals of oncology, 9, 1998, pp. 297-297
ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA TREATED WITH CHOP CHEMOTHERAPY PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR- IDENTIFICATION OF 2 AGE SUBGROUPS WITH DIFFERING HEMATOLOGIC TOXICITY
Authors: GOMEZ H MAS L CASANOVA L PEN DLK SANTILLANA S VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: H. Gomez et al., ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA TREATED WITH CHOP CHEMOTHERAPY PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR- IDENTIFICATION OF 2 AGE SUBGROUPS WITH DIFFERING HEMATOLOGIC TOXICITY, Journal of clinical oncology, 16(7), 1998, pp. 2352-2358
RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS
Authors: GOMEZ H HIDALGO M CASANOVA L COLOMER R PEN DLK OTERO J RODRIGUEZ W CARRACEDO C CORTESFUNES H VALLEJOS C
Citation: H. Gomez et al., RISK-FACTORS FOR TREATMENT-RELATED DEATH IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - RESULTS OF A MULTIVARIATE-ANALYSIS, Journal of clinical oncology, 16(6), 1998, pp. 2065-2069
FACTOR-V-LEIDEN (R506Q) AND RISK OF VENOUS THROMBOEMBOLISM - A CASE-CONTROL STUDY BASED ON THE SPANISH POPULATION
Authors: GARCIAGALA JM ALVAREZ V PINTO CR SOTO I URGELLES MF MENENDEZ MJ CARRACEDO C LOPEZLARREA C COTO E
Citation: Jm. Garciagala et al., FACTOR-V-LEIDEN (R506Q) AND RISK OF VENOUS THROMBOEMBOLISM - A CASE-CONTROL STUDY BASED ON THE SPANISH POPULATION, Clinical genetics, 52(4), 1997, pp. 206-210
AGE-RELATED TOXICITY PATTERN OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GMCSF) IN AGGRESSIVE MALIGNANT-LYMPHOMA PATIENTS (PTS) TREATED WITH CHEMOTHERAPY (CT)
Authors: SANTILLANA S GOMEZ H CASANOVA L KAHATT C VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: S. Santillana et al., AGE-RELATED TOXICITY PATTERN OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GMCSF) IN AGGRESSIVE MALIGNANT-LYMPHOMA PATIENTS (PTS) TREATED WITH CHEMOTHERAPY (CT), Blood, 86(10), 1995, pp. 2799-2799
DIFFERENCES IN EFFICACY AND TOLERANCE IN ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA (NHL) TREATED WITH FULL-DOSE CHOP AND GM-CSF
Authors: GOMEZ H SANTILLANA S CASANOVA L MAS L VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: H. Gomez et al., DIFFERENCES IN EFFICACY AND TOLERANCE IN ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA (NHL) TREATED WITH FULL-DOSE CHOP AND GM-CSF, Blood, 86(10), 1995, pp. 3239-3239
IMPACT OF GMCSF (MOLGRAMOSTIN) IN THE DELIVERY OF FULL DOSE CHOP FOR ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA
Authors: GOMEZ H MAS L CASANOVA L SANTILLANA S VALDIVIA S OTERO J RODRIGUEZ W CARRACEDO C VALLEJOS C
Citation: H. Gomez et al., IMPACT OF GMCSF (MOLGRAMOSTIN) IN THE DELIVERY OF FULL DOSE CHOP FOR ELDERLY PATIENTS WITH INTERMEDIATE GRADE LYMPHOMA, Blood, 84(10), 1994, pp. 10000582-10000582
Risultati: 1-8 |